Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up

In the pharma industry, there are blockbuster drugs and—for the truly fortunate companies—mega blockbusters. However, Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro are in a category all to themselves, which is confounding analysts trying to get a handle on their potential market size amid the frenzied demand for these weight-loss medicines.